{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:05:00Z","timestamp":1758873900501},"reference-count":12,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.mayocp.2015.06.015","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T01:02:34Z","timestamp":1438218154000},"page":"1294-1297","source":"Crossref","is-referenced-by-count":10,"title":["Serious Pulmonary Toxicity Secondary to Novel Hepatitis C Antiviral Therapy in a Liver Transplant Recipient"],"prefix":"10.1016","volume":"90","author":[{"given":"Richard A.","family":"Helmers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis J.","family":"Wesselius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin O.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mayocp.2015.06.015_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11938-014-0013-z","article-title":"Update on recently approved treatments for hepatitis C","volume":"12","author":"Chao","year":"2014","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"6, suppl","key":"10.1016\/j.mayocp.2015.06.015_bib2","first-page":"1379A","article-title":"SVR results of a once-daily regimen of simeprevir (TMC435) plus sofosbuvir (GS-7977) with or without ribavirin in cirrhotic and non-cirrhotic HCV genotype 1 treatment-na\u00efve and prior null responder patients: the COSMOS study","volume":"58","author":"Jacobson","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mayocp.2015.06.015_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/hep.27151","article-title":"Cost analysis of sofosbuvir\/ribavirin versus sofosbuvir\/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible\/intolerant individuals","volume":"60","author":"Hagan","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mayocp.2015.06.015_bib4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2002.32418","article-title":"The association between hepatitis C infection and survival after orthotopic liver transplantation","volume":"122","author":"Forman","year":"2002","journal-title":"Gastroenterology"},{"issue":"13","key":"10.1016\/j.mayocp.2015.06.015_bib5","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199603283341302","article-title":"Long-term outcome of hepatitis C infection after liver transplantation","volume":"334","author":"Gane","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.mayocp.2015.06.015_bib6","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/ajt.12714","article-title":"Directly active antivirals (DAAs) for the treatment of chronic hepatitis C virus infection in liver transplant patients: \u201ca flood of opportunity\u201d","volume":"14","author":"Gane","year":"2014","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.mayocp.2015.06.015_bib7","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/hep.27770","article-title":"Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant","volume":"61","author":"Pungpapong","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mayocp.2015.06.015_bib8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3748\/wjg.v21.i3.1009","article-title":"Simeprevir with peginterferon and ribavirin induced interstitial pneumonitis: first case report","volume":"21","author":"Tamaki","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.06.015_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1378\/chest.07-0104","article-title":"Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy","volume":"132","author":"Parambil","year":"2007","journal-title":"Chest"},{"issue":"16","key":"10.1016\/j.mayocp.2015.06.015_bib10","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMoa1316366","article-title":"Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2015.06.015_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/liv.12424","article-title":"Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir","volume":"34","author":"Asselah","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.mayocp.2015.06.015_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/DHPS.S43304","article-title":"Benefit-risk assessment of new and emerging treatments for hepatitis C: focus on simeprevir and sofosbuvir","volume":"6","author":"Gaetano","year":"2014","journal-title":"Drug Healthc Patient Saf"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619615005157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619615005157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T15:27:01Z","timestamp":1537457221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619615005157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0025619615005157"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2015.06.015","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}